 Ricko Rask
Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myopia | 2 | 1996 | 47 | 0.240 |
Why?
| | Receptors, Complement | 4 | 1989 | 122 | 0.230 |
Why?
| | Cornea | 2 | 1996 | 138 | 0.220 |
Why?
| | Wound Healing | 2 | 1996 | 331 | 0.200 |
Why?
| | Photorefractive Keratectomy | 1 | 1996 | 19 | 0.130 |
Why?
| | Choroid Neoplasms | 1 | 1995 | 7 | 0.120 |
Why?
| | Prednisolone | 1 | 1995 | 83 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 2 | 1995 | 752 | 0.090 |
Why?
| | Lung Neoplasms | 7 | 1990 | 2526 | 0.080 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 37 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 2 | 1989 | 558 | 0.080 |
Why?
| | Antigen-Antibody Complex | 1 | 1989 | 90 | 0.080 |
Why?
| | Erythrocyte Membrane | 1 | 1989 | 55 | 0.080 |
Why?
| | Melanoma | 1 | 1995 | 760 | 0.070 |
Why?
| | Mediastinal Neoplasms | 2 | 1979 | 45 | 0.070 |
Why?
| | B-Lymphocytes | 3 | 1988 | 847 | 0.060 |
Why?
| | Epithelium | 2 | 1996 | 313 | 0.060 |
Why?
| | Video Recording | 2 | 1995 | 180 | 0.050 |
Why?
| | Ultrasonography | 2 | 1995 | 759 | 0.040 |
Why?
| | Leiomyosarcoma | 1 | 1981 | 28 | 0.040 |
Why?
| | Bronchial Neoplasms | 1 | 1980 | 15 | 0.040 |
Why?
| | Lipoma | 1 | 1980 | 16 | 0.040 |
Why?
| | Chondrosarcoma | 1 | 1979 | 16 | 0.040 |
Why?
| | Receptors, Complement 3d | 3 | 1989 | 141 | 0.040 |
Why?
| | Pheochromocytoma | 1 | 1979 | 59 | 0.040 |
Why?
| | Evaluation Studies as Topic | 2 | 1995 | 180 | 0.040 |
Why?
| | Time Factors | 3 | 1996 | 6828 | 0.030 |
Why?
| | Lasers, Excimer | 1 | 1996 | 28 | 0.030 |
Why?
| | Ruthenium Radioisotopes | 1 | 1995 | 1 | 0.030 |
Why?
| | Chloramphenicol | 1 | 1995 | 9 | 0.030 |
Why?
| | Ointments | 1 | 1995 | 25 | 0.030 |
Why?
| | Middle Aged | 9 | 1996 | 33479 | 0.030 |
Why?
| | Remission Induction | 1 | 1995 | 288 | 0.030 |
Why?
| | Administration, Topical | 1 | 1995 | 151 | 0.030 |
Why?
| | Brachytherapy | 1 | 1995 | 121 | 0.030 |
Why?
| | Lenses, Intraocular | 1 | 1995 | 43 | 0.030 |
Why?
| | Eye | 1 | 1995 | 108 | 0.030 |
Why?
| | Cataract Extraction | 1 | 1995 | 98 | 0.030 |
Why?
| | Laser Therapy | 1 | 1995 | 130 | 0.030 |
Why?
| | Adult | 7 | 1996 | 37929 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 1995 | 1066 | 0.020 |
Why?
| | Models, Theoretical | 1 | 1995 | 578 | 0.020 |
Why?
| | Palatine Tonsil | 2 | 1989 | 48 | 0.020 |
Why?
| | Neoplasm Metastasis | 3 | 1979 | 658 | 0.020 |
Why?
| | Humans | 17 | 1996 | 137585 | 0.020 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 1972 | 80 | 0.020 |
Why?
| | Carcinoma, Squamous Cell | 2 | 1990 | 683 | 0.020 |
Why?
| | Rectal Neoplasms | 1 | 1972 | 149 | 0.020 |
Why?
| | Pneumonectomy | 2 | 1990 | 152 | 0.020 |
Why?
| | Carcinoma, Small Cell | 1 | 1990 | 172 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1989 | 88 | 0.020 |
Why?
| | Macrophage-1 Antigen | 1 | 1988 | 28 | 0.020 |
Why?
| | Adenocarcinoma | 2 | 1990 | 940 | 0.020 |
Why?
| | Receptors, Complement 3b | 1 | 1989 | 84 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 1988 | 852 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 345 | 0.020 |
Why?
| | Male | 9 | 1995 | 67762 | 0.020 |
Why?
| | Receptors, Virus | 1 | 1988 | 83 | 0.020 |
Why?
| | Prognosis | 1 | 1995 | 4030 | 0.020 |
Why?
| | Herpesvirus 4, Human | 1 | 1988 | 166 | 0.020 |
Why?
| | Blotting, Western | 1 | 1989 | 1226 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 1986 | 44 | 0.020 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1986 | 57 | 0.020 |
Why?
| | Aged | 5 | 1995 | 23961 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 1995 | 7635 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1988 | 1738 | 0.010 |
Why?
| | Female | 5 | 1995 | 73304 | 0.010 |
Why?
| | Femoral Neoplasms | 1 | 1979 | 9 | 0.010 |
Why?
| | Mediastinum | 1 | 1979 | 23 | 0.010 |
Why?
| | Mediastinoscopy | 1 | 1976 | 5 | 0.010 |
Why?
| | Methods | 1 | 1976 | 65 | 0.010 |
Why?
| | Biopsy | 1 | 1979 | 1129 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 1976 | 189 | 0.010 |
Why?
| | Anterior Chamber | 1 | 1995 | 22 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1979 | 1389 | 0.010 |
Why?
| | Biometry | 1 | 1995 | 70 | 0.010 |
Why?
| | Mice | 2 | 1989 | 17787 | 0.010 |
Why?
| | Vitreous Body | 1 | 1995 | 110 | 0.010 |
Why?
| | Animals | 2 | 1989 | 36940 | 0.000 |
Why?
| | Cell Transformation, Viral | 1 | 1988 | 25 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1988 | 80 | 0.000 |
Why?
| | Lung | 1 | 1981 | 4060 | 0.000 |
Why?
| | Cell Line, Transformed | 1 | 1988 | 145 | 0.000 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 219 | 0.000 |
Why?
| | Reproducibility of Results | 1 | 1995 | 3284 | 0.000 |
Why?
| | Cell Line | 1 | 1988 | 2847 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1988 | 1430 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1990 | 5131 | 0.000 |
Why?
| | Immunity, Cellular | 1 | 1981 | 268 | 0.000 |
Why?
| | T-Lymphocytes | 1 | 1981 | 1996 | 0.000 |
Why?
| | Adolescent | 1 | 1972 | 21513 | 0.000 |
Why?
|
|
Rask's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|